ArticleExperimental and therapeutic medicine2019

Role of inflammatory factors in the effects of aflibercept or ranibizumab treatment for alleviating wet age-associated macular degeneration.

Jianshu YuanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.